Q1 2022 Holdings
Filed 2022-05-16 | 94 holdings | $44.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $7.8M | 211,495 | 17.3% |
| Atricure Inc(ATRC) | COM | 04963C209 | $4.7M | 72,029 | 10.5% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $4.6M | 145,217 | 10.2% |
| Alector Inc(ALEC) | COM | 014442107 | $4.2M | 292,747 | 9.3% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $3.6M | 30,612 | 8.0% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $3.2M | 256,892 | 7.2% |
| Accuray Inc(ARAY) | COM | 004397105 | $3.1M | 941,800 | 6.9% |
| Axogen Inc(AXGN) | COM | 05463X106 | $2.6M | 332,103 | 5.9% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $2.3M | 53,200 | 5.2% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $2.1M | 496,150 | 4.6% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $1.7M | 383,923 | 3.8% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $1.7M | 223,554 | 3.7% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $965.0K | 74,890 | 2.1% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $869.0K | 313,600 | 1.9% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $723.0K | 351,064 | 1.6% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $269.0K | 196,091 | 0.6% |
| Annexon Inc(ANNX) | COM | 03589W102 | $84.0K | 30,796 | 0.2% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $51.0K | 13,680,554 | 0.1% |
| Spdr SP Biotech ETF(XBI) | ETF | 78464A870 | $24.2K | 269,500 | 0.1% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $19.4K | 500,930 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $15.7K | 246,280 | 0.0% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $14.3K | 715,872 | 0.0% |
| Ishares TR Nasdaq Biotech Indx(IBB) | ETF | 464287556 | $13.4K | 102,500 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $11.6K | 380,163 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $10.4K | 82,053 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $9.3K | 18,138 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $9.2K | 77,600 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $7.8K | 83,655 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $7.6K | 543,344 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $7.3K | 181,467 | 0.0% |
| Cardiovascular SYS Inc(CSIIEUR) | COM | 141619106 | $6.5K | 286,988 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $6.5K | 371,987 | 0.0% |
| Merus N V | COM | N5749R100 | $6.2K | 234,989 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $6.0K | 180,306 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $5.9K | 232,101 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $5.5K | 490,061 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $5.3K | 1,692,569 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $5.0K | 298,476 | 0.0% |
| Natus Medical Inc | COM | 639050103 | $5.0K | 190,635 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $4.8K | 93,935 | 0.0% |
| Radius Health Inc | NOTE 3.000% 9/0 | 750469AA6 | $3.9K | $4,000,000 | 0.0% |
| Otonomy Inc | COM | 68906L105 | $3.6K | 1,497,514 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $3.5K | 42,700 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $3.5K | 356,750 | 0.0% |
| Pardes Biosciences Inc | COM | 69945Q105 | $3.0K | 421,157 | 0.0% |
| Field Trip Health LTD | COM | 31656R102 | $2.9K | 2,191,308 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $2.9K | 89,298 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $2.8K | 190,663 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $2.7K | 896,100 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $2.6K | 42,675 | 0.0% |